Brain Scientific Stock Cash Flow From Operations
BRSF Stock | USD 0.75 0.00 0.00% |
Brain Scientific fundamentals help investors to digest information that contributes to Brain Scientific's financial success or failures. It also enables traders to predict the movement of Brain Pink Sheet. The fundamental analysis module provides a way to measure Brain Scientific's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Brain Scientific pink sheet.
Brain |
Brain Scientific Company Cash Flow From Operations Analysis
Brain Scientific's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Brain Scientific Cash Flow From Operations | (5.87 M) |
Most of Brain Scientific's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Brain Scientific is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Competition |
In accordance with the recently published financial statements, Brain Scientific has (5.87 Million) in Cash Flow From Operations. This is 101.11% lower than that of the Healthcare sector and 101.61% lower than that of the Medical Devices industry. The cash flow from operations for all United States stocks is 100.6% higher than that of the company.
Brain Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Brain Scientific's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Brain Scientific could also be used in its relative valuation, which is a method of valuing Brain Scientific by comparing valuation metrics of similar companies.Brain Scientific is currently under evaluation in cash flow from operations category among its peers.
Brain Fundamentals
Return On Equity | -45.97 | |||
Return On Asset | -1.17 | |||
Operating Margin | (28.77) % | |||
Current Valuation | 12.28 M | |||
Shares Outstanding | 105.4 M | |||
Shares Owned By Insiders | 23.83 % | |||
Shares Owned By Institutions | 18.54 % | |||
Price To Sales | 26.56 X | |||
Revenue | 265.75 K | |||
Gross Profit | 83.23 K | |||
EBITDA | (8.32 M) | |||
Net Income | (9.1 M) | |||
Cash And Equivalents | 3.54 M | |||
Cash Per Share | 0.03 X | |||
Total Debt | 9.97 M | |||
Debt To Equity | 0.18 % | |||
Current Ratio | 0.59 X | |||
Book Value Per Share | 0.07 X | |||
Cash Flow From Operations | (5.87 M) | |||
Earnings Per Share | (0.29) X | |||
Number Of Employees | 28 | |||
Beta | -0.88 | |||
Market Capitalization | 316.21 M | |||
Total Asset | 13.38 M | |||
Z Score | 18.6 | |||
Net Asset | 13.38 M |
About Brain Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Brain Scientific's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brain Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brain Scientific based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
IBTA | Ibotta, | |
DTST | Data Storage Corp | |
ESRT | Empire State Realty | |
IBTA | Ibotta, | |
GTES | Gates Industrial |
Other Information on Investing in Brain Pink Sheet
Brain Scientific financial ratios help investors to determine whether Brain Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Brain with respect to the benefits of owning Brain Scientific security.